Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.5B | 14.2B | 15.1B | 13.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.1B | 1.1B | 1.1B | 1.1B |
| Other operating expenses | 12M | 8M | 7M | 17M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 181M | 189M | 192M | 182M |
| Other income expense | — | 98M | -230M | -29M |
| Pretax income | 1.7B | 3.1B | 3.0B | 2.7B |
| Tax provision | 321M | 479M | 504M | 490M |
| Net income | 1.3B | 2.6B | 2.5B | 2.2B |
| Basic EPS | 3.3 | 6.3 | 5.8 | 5.5 |
| Diluted EPS | 3.3 | 6.0 | 5.7 | 5.5 |
| Basic average shares | 400.7M | 406.9M | 403.0M | 404.1M |
| Diluted average shares | 404.7M | 427.7M | 407.9M | 408.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.3B | 2.6B | 2.5B | 2.2B |
| Minority interests | -12M | -65M | -166M | 14M |
| Preferred stock dividends | — | — | — | — |